Literature DB >> 9929157

Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells.

O Nagakawa1, M Ogasawara, H Fujii, K Murakami, J Murata, H Fuse, I Saiki.   

Abstract

We investigated the effect of various neuropeptides present in the prostate, including calcitonin gene-related peptide (CGRP), gastrin-releasing peptide (GRP), substance P (SP), neuropeptide Y (NPY), vasoactive intestinal polypeptide (VIP), calcitonin (CT), leucine-enkephalin (L-ENK), glucagon and parathyroid hormone-related protein (PTH-rP), on the invasion of PC-3 prostate cancer cells through a reconstituted basement membrane (Matrigel) using a Transwell cell culture chamber assay. Both CGRP and GRP increased the invasive capacity of tumor cells, whereas SP inhibited it. On the other hand, VIP, CT, L-ENK, NPY, glucagon and PTH-rP had no significant effect. Both CGRP and GRP also increased the haptotactic migration of tumor cells to fibronectin, but SP inhibited it. These three neuropeptides had no effect on either adhesion to fibronectin and laminin or on the gelatinolytic activities of MMP-9 in gelatin zymography, nor did they affect the growth of tumor cells at concentrations used in this study. These results indicate that both GRP and CGRP increased the invasive potential of PC-3 cells probably through enhancement of cell motility, while SP inhibited the invasiveness through suppression of motile response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9929157     DOI: 10.1016/s0304-3835(98)00186-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Sensory Neurotransmitter Calcitonin Gene-Related Peptide Modulates Tumor Growth and Lymphocyte Infiltration in Oral Squamous Cell Carcinoma.

Authors:  Lisa A McIlvried; Megan A Atherton; Nicole L Horan; Tori N Goch; Nicole N Scheff
Journal:  Adv Biol (Weinh)       Date:  2022-04-07

2.  Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer.

Authors:  Constantinos Constantinides; Andreas C Lazaris; Konstantinos N Haritopoulos; Dimitrios Pantazopoulos; Michalis Chrisofos; Aris Giannopoulos
Journal:  World J Urol       Date:  2003-07-05       Impact factor: 4.226

3.  Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.

Authors:  Girish V Shah; Anbalagan Muralidharan; Shibu Thomas; Mitan Gokulgandhi; Mudit Mudit; Mohammad Khanfar; Khalid El Sayed
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

4.  Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.

Authors:  Shibu Thomas; Maurizio Chiriva-Internati; Girish V Shah
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

5.  RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.

Authors:  Monica Logan; Philip D Anderson; Shahrazad T Saab; Omar Hameed; Sarki A Abdulkadir
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

6.  Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.

Authors:  Patrick Fournier; Véronique Dumulon-Perreault; Samia Ait-Mohand; Réjean Langlois; François Bénard; Roger Lecomte; Brigitte Guérin
Journal:  EJNMMI Res       Date:  2012-02-14       Impact factor: 3.138

7.  Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells.

Authors:  Xiaodong Wen; Celia Chao; Kirk Ives; Mark R Hellmich
Journal:  BMC Mol Biol       Date:  2011-07-11       Impact factor: 2.946

Review 8.  The Role of the Calcitonin Peptide Family in Prostate Cancer and Bone Metastasis.

Authors:  Jessica Isabel Warrington; Gareth Owain Richards; Ning Wang
Journal:  Curr Mol Biol Rep       Date:  2017-08-02

9.  Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.

Authors:  Petra Massoner; Karl G Kugler; Karin Unterberger; Ruprecht Kuner; Laurin A J Mueller; Maria Fälth; Georg Schäfer; Christof Seifarth; Simone Ecker; Irmgard Verdorfer; Armin Graber; Holger Sültmann; Helmut Klocker
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

10.  Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling.

Authors:  Pritha Paul; Jingbo Qiao; Kwang Woon Kim; Carmelle Romain; Sora Lee; Natasha Volny; Bret Mobley; Hernan Correa; Dai H Chung
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.